Copyright 2009 Medical News Today Latest Erectile Dysfunction / Premature Ejaculation News From Medical News Today. http://www.medicalnewstoday.com/sections/erectile_dysfunction/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Wed, 01 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155875.php http://www.medicalnewstoday.com/articles/155875.php Two Indiana University studies conducted among nationally representative samples of adult American men and women show that vibrator use during sexual interactions is common, with use being reported by approximately 53 percent of women and 45 percent of men ages 18 to 60. Not only is vibrator use common, but the two studies also show that vibrator use is associated with more positive sexual function and being more proactive in caring for one's sexual health. Sexual Health / STDs Wed, 10 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/153222.php http://www.medicalnewstoday.com/articles/153222.php A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions. Prostate / Prostate Cancer Sat, 06 Jun 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/152856.php http://www.medicalnewstoday.com/articles/152856.php UroToday.com - Together with Drs. Heruti, Bechor, Justo and Galor, we studied 815 Israeli male adults of whom 305 had complete data and were included in the statistical analysis. In the analyzed population, 2.1% of people without erectile dysfunction (ED) had advanced periodontal disease (defined as recession of periodontal bone of 6 mm or more) in comparison to 9.8% of the mild ED and 15.8% of the moderate/severe ED populations, respectively. Erectile Dysfunction / Premature Ejaculation Sat, 30 May 2009 09:00:00 PDT http://www.medicalnewstoday.com/articles/151978.php http://www.medicalnewstoday.com/articles/151978.php UroToday.com - This updated review of tadalafil (Cialis), one of the three available phosphodiesterase type 5 (PDE5) inhibitors that revolutionized the treatment of erectile dysfunction (ED), analyzes its latest clinical studies. Tadalafil's most unique and identifying characteristic is its long half-life of 17.5 hours, compared with 4 hours for sildenafil (Viagra) and vardenafil (Levitra). Erectile Dysfunction / Premature Ejaculation Thu, 28 May 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/151727.php http://www.medicalnewstoday.com/articles/151727.php Premature ejaculation can be embarrassing, but a new study suggests that it might be a genetic disorder. Researchers from Turku, Finland, interviewed more than three thousand men - all pairs of male twins and their older or younger brothers - about the first time they had sex. Many participants in the study reported that they had suffered from erectile dysfunction and premature ejaculation at their first sexual encounter. Erectile Dysfunction / Premature Ejaculation Thu, 14 May 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/149949.php http://www.medicalnewstoday.com/articles/149949.php VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health, announced that it has initiated an open label safety study (TA-314) with its investigational drug, avanafil, in males with erectile dysfunction (ED). Erectile Dysfunction / Premature Ejaculation Thu, 07 May 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/149117.php http://www.medicalnewstoday.com/articles/149117.php Eli Lilly and Company (NYSE: LLY) announced results from a double-blind, placebo-controlled study which showed that tadalafil 5 mg dose taken once daily was generally well-tolerated, improved erectile function for men with erectile dysfunction (ED) and reported improvement in the sexual quality of life scores for men and their female partners. Erectile Dysfunction / Premature Ejaculation Wed, 06 May 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/148931.php http://www.medicalnewstoday.com/articles/148931.php Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN) announced preliminary results for its sexual dysfunction drug candidate, Zoraxel™, from a Phase IIa clinical study for the treatment of erectile dysfunction (ED). Erectile Dysfunction / Premature Ejaculation Wed, 29 Apr 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/148156.php http://www.medicalnewstoday.com/articles/148156.php Sciele Pharma, Inc. a Shiongi Company, and Plethora Solutions Holdings PLC ("Plethora" - AME:PLE) today presented highly encouraging results from a European Phase III randomized, double-blind, placebo-controlled study of PSD502 for the treatment of premature ejaculation (PE). In this study, men treated with PSD502 five minutes before intercourse were able to delay ejaculation up to six times longer than those who used a placebo. Erectile Dysfunction / Premature Ejaculation Tue, 28 Apr 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/147752.php http://www.medicalnewstoday.com/articles/147752.php Several new studies presented at the American Urological Association's (AUA) 104th Annual Scientific Meeting suggest that the use of statins--commonly prescribed to lower cholesterol--may benefit men with prostate cancer, erectile dysfunction or lower urinary tract symptoms (LUTS). Several key research studies highlighting these benefits will be presented during a special panel for the media on Monday, April 27 from 9 to 10:30 a.m. Urology / Nephrology Mon, 27 Apr 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/147645.php http://www.medicalnewstoday.com/articles/147645.php Cutaneous application of nanoparticles may offer a new means of delivering drugs to treat erectile dysfunction (ED), according to findings presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). Topical treatments for ED may offer localized therapeutic results with the benefit of lower dosage and the avoidance of adverse side effects due to systemic absorption. Erectile Dysfunction / Premature Ejaculation Mon, 27 Apr 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/147638.php http://www.medicalnewstoday.com/articles/147638.php Men taking generic drugs may be more likely to have less effective results and more adverse events than if they were using branded medications, according to new data from researchers in New York. Prostate / Prostate Cancer Mon, 27 Apr 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/147620.php http://www.medicalnewstoday.com/articles/147620.php Statins, drugs widely prescribed to lower cholesterol, may have protective effects on prostate health. This large Mayo Clinic cohort study looked at three different aspects of urological health -- prostate cancer, erectile dysfunction and prostate enlargement. Initial research results are being presented April 25-30, 2009, at the American Urological Association (AUA) meeting in Chicago. Statins Mon, 27 Apr 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/147636.php http://www.medicalnewstoday.com/articles/147636.php Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia (BPH). Researchers from Nashville, Dallas, San Antonia and Indianapolis presented these findings during the 104th Annual Scientific Meeting of the American Urological Association (AUA). Prostate / Prostate Cancer Sun, 26 Apr 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/147583.php http://www.medicalnewstoday.com/articles/147583.php UroToday.com - The concept behind nerve grafting is to make use of one's own nerves, which play a minimal functional role, as conduits to promote the regrowth of new nerve fibers. In certain patients with prostate cancer, the nerves crucial for erectile function (cavernous nerves) may need to be cut in the interest of removing high-risk cancer. In these situations, the genitofemoral nerve can be interposed (grafted) as a conduit to promote regrowth of new nerve fibers. Erectile Dysfunction / Premature Ejaculation Thu, 16 Apr 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/146224.php http://www.medicalnewstoday.com/articles/146224.php Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although surveyed primary care physicians (PCPs) are generally satisfied with the efficacy of available phosphodiesterase type 5 (PDE5) inhibitors such as Pfizer's Viagra, Eli Lilly's Cialis and Bayer Healthcare/Schering-Plough/GlaxoSmithKline's Levitra, they are less satisfied with the efficacy of this drug class in difficult-to-treat patient subpopulations. Erectile Dysfunction / Premature Ejaculation Tue, 07 Apr 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/145318.php http://www.medicalnewstoday.com/articles/145318.php Men with premature ejaculation who used a topical spray five minutes before intercourse were able to delay their orgasm six times longer than normal, according to a study in the April issue of BJU International. Three hundred men with clinically diagnosed lifelong premature ejaculation (PE) from 31 centres in the UK, Czech Republic, Hungary and Poland, were randomised into two groups. Two hundred used the PSD502 spray, which contains 7.5mg of lidocaine and 2. Erectile Dysfunction / Premature Ejaculation Thu, 02 Apr 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/144558.php http://www.medicalnewstoday.com/articles/144558.php It certainly could, especially for men suffering from obesity-related erectile dysfunction. A clinical study recently published in The Journal of Sexual Medicine showed that obese men with erectile dysfunction had low levels of testosterone. As the severity of obesity increased, the levels of testosterone further decreased. Excess abdominal fat, cardiovascular disease, high blood lipids and type 2 diabetes have been associated with erectile dysfunction. Obesity / Weight Loss / Fitness Wed, 25 Mar 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/143580.php http://www.medicalnewstoday.com/articles/143580.php South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition. A UK study carried out by the University of Warwick shows diabetic retinopathy (damage to the retina) is more prevalent in South Asians and occurs earlier than in White European people with diabetes. The study, published in the latest issue of Diabetes Care, looked at 1. Diabetes Fri, 20 Mar 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/143004.php http://www.medicalnewstoday.com/articles/143004.php The panel initially covering the topic of Erectile Dysfunction have broadened the scope of their guidelines and have taken in the treatment of premature ejaculation in their updated document. Since the prior limited update of this guideline considerable data have become available regarding the various drugs on the market for the treatment of erectile dysfunction. Erectile Dysfunction / Premature Ejaculation Sun, 01 Mar 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/140658.php http://www.medicalnewstoday.com/articles/140658.php UroToday.com - The report, one of four published articles from a population-based cross-sectional study principally on male erectile dysfunction (ED), is based on the responses of 1,580 participants to questions on their alcohol drinking behaviour. To assess the effects of alcohol on erectile function was not the primary objective of the study. Erectile Dysfunction / Premature Ejaculation Fri, 20 Feb 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/139663.php http://www.medicalnewstoday.com/articles/139663.php Sciele Pharma, Inc., a Shionogi company, and Plethora Solutions Holdings PLC ("Plethora," AIM: PLE), today announced the completion of patient recruitment of the PSD502 registration program for the treatment of premature ejaculation (PE). The preliminary results from this North American study are expected in mid-year 2009. A parallel European Phase III study of PSD502 concluded successfully in November 2008 with a positive outcome that was both clinically and statistically significant. Erectile Dysfunction / Premature Ejaculation Sun, 15 Feb 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/138890.php http://www.medicalnewstoday.com/articles/138890.php Pfizer's inaugural Asia Pacific Sexual Health and Overall Wellness (AP SHOW) survey has uncovered staggering levels of sexual dissatisfaction, with 60% of men and around 60% of women in Australia saying they are not very satisfied with their sex lives. Erectile Dysfunction (ED) continues to be a key cause of dissatisfaction. Erectile Dysfunction / Premature Ejaculation Thu, 12 Feb 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/138782.php http://www.medicalnewstoday.com/articles/138782.php VIVUS, Inc. (NASDAQ: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced it has initiated a second pivotal Phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED). Avanafil is a next-generation, fast-acting, selective, investigational oral phosphodiesterase type 5 (PDE5) inhibitor. Erectile Dysfunction / Premature Ejaculation Thu, 05 Feb 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/137913.php http://www.medicalnewstoday.com/articles/137913.php The conversation about male sexual dysfunction has grown from a whisper to a roar. From Bob Dole to Mike Ditka, erectile dysfunction, or ED, is no longer hush-hush as more men are talking more openly. Non-stop commercials convey help in the bedroom is just a prescription away. Erectile Dysfunction / Premature Ejaculation